SE389866B - Forfarande for framstellning av i 1-stellning substituerade 3-(4-(2-(subst nikotinamido)-etyl)-benzensulfonyl)-karbamider - Google Patents

Forfarande for framstellning av i 1-stellning substituerade 3-(4-(2-(subst nikotinamido)-etyl)-benzensulfonyl)-karbamider

Info

Publication number
SE389866B
SE389866B SE7404364A SE7404364A SE389866B SE 389866 B SE389866 B SE 389866B SE 7404364 A SE7404364 A SE 7404364A SE 7404364 A SE7404364 A SE 7404364A SE 389866 B SE389866 B SE 389866B
Authority
SE
Sweden
Prior art keywords
nicotinamido
benzenesulphonyl
subst
urban
ethyl
Prior art date
Application number
SE7404364A
Other languages
English (en)
Swedish (sv)
Inventor
D E Kuhla
R Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE389866B publication Critical patent/SE389866B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/803—Processes of preparation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7404364A 1973-05-04 1974-04-01 Forfarande for framstellning av i 1-stellning substituerade 3-(4-(2-(subst nikotinamido)-etyl)-benzensulfonyl)-karbamider SE389866B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US357466A US3879403A (en) 1973-05-04 1973-05-04 Benzenesulfonylurea derivatives

Publications (1)

Publication Number Publication Date
SE389866B true SE389866B (sv) 1976-11-22

Family

ID=23405725

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7404364A SE389866B (sv) 1973-05-04 1974-04-01 Forfarande for framstellning av i 1-stellning substituerade 3-(4-(2-(subst nikotinamido)-etyl)-benzensulfonyl)-karbamider

Country Status (27)

Country Link
US (1) US3879403A (fr)
JP (1) JPS5839829B2 (fr)
AR (1) AR202815A1 (fr)
AT (1) AT342615B (fr)
AU (1) AU460423B2 (fr)
BE (1) BE813807A (fr)
BG (1) BG25080A3 (fr)
CA (1) CA1010042A (fr)
CH (1) CH582675A5 (fr)
CS (1) CS191232B2 (fr)
DD (1) DD111679A5 (fr)
DE (1) DE2419198C3 (fr)
DK (1) DK141749B (fr)
ES (1) ES425343A1 (fr)
FI (1) FI55498C (fr)
FR (1) FR2227865B1 (fr)
GB (1) GB1450801A (fr)
HU (1) HU166760B (fr)
IE (1) IE39116B1 (fr)
IL (1) IL44570A (fr)
LU (1) LU69889A1 (fr)
NL (1) NL171053C (fr)
PL (1) PL96708B1 (fr)
RO (2) RO64480A (fr)
SE (1) SE389866B (fr)
SU (1) SU632300A3 (fr)
YU (1) YU106174A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2706977A1 (de) * 1977-02-18 1978-08-24 Hoechst Ag Benzoesaeuren und deren derivate sowie verfahren zu ihrer herstellung
DE2720926C2 (de) * 1977-05-10 1983-02-17 Hoechst Ag, 6000 Frankfurt Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung
DK455480A (da) * 1979-11-30 1981-05-31 Du Pont Fremgangsmaade til fremstilling af herbicide n- (substituerede heterocycliske aminocarbonyl)-aromatiske sulfonamider
US4716231A (en) * 1987-04-27 1987-12-29 Pfizer Inc. Chlorination of 2-methoxynicotinic acid
JPH042618U (fr) * 1990-04-25 1992-01-10
JP5148836B2 (ja) * 2005-04-21 2013-02-20 石原産業株式会社 ニコチン酸誘導体又はその塩の製造方法
US8039633B2 (en) * 2005-04-21 2011-10-18 Ishihara Sangyo Kaisha, Ltd. Method for producing nicotinic acid derivative or salt thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1031088A (en) * 1964-04-16 1966-05-25 Hoechst Ag Benzenesulphonyl-ureas and process for their manufacture

Also Published As

Publication number Publication date
BG25080A3 (en) 1978-07-12
JPS5013379A (fr) 1975-02-12
CA1010042A (en) 1977-05-10
FR2227865A1 (fr) 1974-11-29
NL7405187A (fr) 1974-11-06
DE2419198B2 (de) 1980-04-10
DK141749C (fr) 1980-10-27
RO69254A (fr) 1982-09-09
PL96708B1 (pl) 1978-01-31
DK141749B (da) 1980-06-09
DE2419198A1 (de) 1974-11-14
IL44570A (en) 1977-01-31
NL171053C (nl) 1983-02-01
AT342615B (de) 1978-04-10
DD111679A5 (fr) 1975-03-05
FI55498B (fi) 1979-04-30
IE39116L (en) 1974-11-04
RO64480A (fr) 1979-05-15
LU69889A1 (fr) 1974-11-21
NL171053B (nl) 1982-09-01
SU632300A3 (ru) 1978-11-05
FI55498C (fi) 1979-08-10
CS191232B2 (en) 1979-06-29
GB1450801A (en) 1976-09-29
BE813807A (fr) 1974-10-17
AU460423B2 (en) 1975-04-07
ATA316874A (de) 1977-08-15
CH582675A5 (fr) 1976-12-15
ES425343A1 (es) 1976-06-01
JPS5839829B2 (ja) 1983-09-01
US3879403A (en) 1975-04-22
IE39116B1 (en) 1978-08-02
FR2227865B1 (fr) 1977-08-19
HU166760B (fr) 1975-05-28
AR202815A1 (es) 1975-07-24
IL44570A0 (en) 1974-06-30
YU106174A (en) 1982-02-28
AU6759874A (en)
DE2419198C3 (de) 1980-12-11

Similar Documents

Publication Publication Date Title
NO144568C (no) Analogifremgangsmaate til fremstilling av 3-substituerte 4-fenylpiperidiner
AR204753A1 (es) Procedimiento para la obtencion de derivados del 4 o 5-(3-(4-(fenil)-piperazinil-1)-propoxi)-indol
NO137897C (no) Fremgangsmaate til fremstilling av optisk aktive 1,4-benzdiazepin-2-on-derivater
DK134177C (da) Fremgangsmade til fremstilling af 3-(piperazinoalkyl)-pyrazoler
AR211860A1 (es) Procedimiento para la elaboracion de nuevos derivados de la 4-(2-benzofuranil)-piperidina
SE405598B (sv) Forfarande for framstellning av nya terapeutiskt verksamma derivat av 4-(3-amino-2-hydroxi-propoxi)-indol
AR204175A1 (es) Procedimiento de preparacion de 2-(3-(4 difenimetil-1-piperazinil)-propil)-s-triazol-(1,5-a)piridina y sus sales de adicion de acidos
SE397525B (sv) Sett att framstella nya 1-ocyl-3-indolinetanoler att anvendas som mellanprodukter for framstellning av 3-(2-(4-fenyl-1-piperazinyl)-etyl)-indoliner
DK135895B (da) Analogifremgangsmåde til fremstilling af derivater af 4'-fluor-4-(4-(alfa-hydroxybenzyl)piperidino)butyrophenoner.
SE7608956L (sv) Forfarande for framstellning av 2-(fenoxialkyltio)-5-nitroimidazoler
SE7600890L (sv) Forfarande for framstellning av 2-(6'-karbometoxihexyl)-2-cyklopenten-1-on
IL37633A (en) 2-(4-(2-benzoxazolyl)phenyl)alkanoic acid derivatives
AR204105A1 (es) Procedimiento para la preparacion del 1-(4-(2-metiltioetoxi-fenoxi)-2-hidroxi-3-isipropilaminopropano
NO741133L (no) Fremgangsmåte for fremstilling av metyl-3-(2-kinoksalinylmetylen)-karbazat-N1.N4-dioksyd.
DK139673B (da) Analogifremgangsmåde til fremstilling af 2-(4-(2-fluorfenoxy)-fenyl)-propionsyrederivater.
AT292704B (de) Verfahren zur Herstellung von neuen 4-(Pyridyl)-tetrahydropyranen, -tetrahydrothiopyranen oder -piperidinen
SE398500B (sv) Forfarande for framstellning av 2-(3-legre alkylamino-2-hydroxipropyl)-3-fenylpyrazin
SE7605518L (sv) Forfarande for framstellning av 3,5-bisoxygenerade 2-(omega-halogen-3-oxygenerad-l-alkenyl)cyklopentan-l-heptansyror och derivat derav
DK130309B (da) Analogifremgangsmåde til fremstilling af 3-(3β-tridigitoxosyl-14β-hydroxy-5β-androstan-17β-yl)-acrylsyreforbindelser.
SE412587B (sv) Forfarande for framstellning av substituerade imidazoler
AU452870B2 (en) 4-(heterocyclic)-salicylic acid derivatives
SE410310B (sv) Forfarande for framstellning av 2-(3,5-dimetoxifenyl)-3-metyloktan
NO151200C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, nye derivater av 4-(3-(4-kinolyl)propyl)-piperidin
DK124685B (da) Fremgangsmåde til fremstilling af 1-[(2'-alkyl-4'-aminopyrimidyl-5')-metyl]-pyridiniumderivater.
CH465579A (de) Verfahren zur Herstellung von in 5-Stellung substituierten 2-(N,N-Dialkyl-bzw. N-Alkyl-N-akloxy-carbamoyl-methoxy)-benzoesäureestern

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7404364-7

Effective date: 19921108

Format of ref document f/p: F